Verana Health

The Verana platform combines state-of-the-art analytics with longitudinal EHR data from the American Academy of Ophthalmology’s IRIS Registry®, the nation’s first comprehensive eye disease clinical registry and the largest specialty-based clinical registry in all of medicine. Verana sheds light on the patient experience across the continuum of ophthalmic care to equip clinical and commercial teams with real-world insights to advance innovation.

Clinical Trial Insights

Though drug and device innovation is rapidly evolving in response to the proliferation of patient health data, randomized, controlled trials are the gold standard when introducing new therapies to market. At Verana, we use information from the largest clinical ophthalmic dataset in the world, combined with advanced analytic tools developed by a team with demonstrated specialty expertise, to accelerate clinical trials.

Market Insights

Reach beyond the limitations of traditional sales and marketing data sources to drive commercial success. Verana enables commercial teams to maintain their competitive edge with real-world clinical data insights that shed light on national and regional market dynamics. Leverage intelligence on market share, patient demographics, and treatment patterns to inform sales and marketing decisions.

Post-Market Clinical Insights

Regulatory agencies increasingly rely on real-world data to drive post-market reimbursement decisions and assess long-term efficacy, safety, and side effect profiles for drugs and devices. The Verana data and technology platform enables life science companies to address post-market clinical needs, from adverse events reporting to utilizing real-world evidence for label expansion, observational studies, and beyond.